ACMAT Corporation
ACMTA
$33.50
$0.000.00%
Weiss Ratings | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | D | |||
Rating Factors | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Very Weak | |||
Efficiency Index | Fair | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.13 | |||
Price History | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | 1.24% | |||
60-Day Total Return | 1.52% | |||
90-Day Total Return | 1.52% | |||
Year to Date Total Return | 1.52% | |||
1-Year Total Return | -4.29% | |||
2-Year Total Return | 9.84% | |||
3-Year Total Return | 3.72% | |||
5-Year Total Return | 63.41% | |||
52-Week High % Change | -4.29% | |||
52-Week Low % Change | 4.65% | |||
Price | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $35.00 | |||
52-Week Low Price | $32.01 | |||
52-Week Low Price (Date) | Oct 10, 2022 | |||
52-Week High Price (Date) | Apr 05, 2022 | |||
Valuation | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | $25.85M | |||
Enterprise Value | 23.80M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -1.80 | |||
Earnings Per Share Growth | -256.64% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 30.17 | |||
Price/Book (Q) | 0.95 | |||
Enterprise Value/Revenue (TTM) | 57.66 | |||
Price | $33.50 | |||
Enterprise Value/EBITDA (TTM) | -12.66 | |||
Enterprise Value/EBIT | -11.35 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 771.500K | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 860 415 8400 | |||
Address | 30 South Road Farmington, CT 06032-2418 | |||
Website | www.acmatcorp.com | |||
Country | United States | |||
Year Founded | 1950 | |||
Profitability | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -508.09% | |||
Profit Margin | -458.66% | |||
Management Effectiveness | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -2.39% | |||
Return on Equity | -- | |||
Income Statement | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | $2.54M | |||
Total Revenue (TTM) | $412.70K | |||
Revenue Per Share | $0.54 | |||
Gross Profit (TTM) | $720.20K | |||
EBITDA (TTM) | -$1.88M | |||
EBIT (TTM) | -$2.10M | |||
Net Income (TTM) | -$1.89M | |||
Net Income Avl. to Common (TTM) | -$1.89M | |||
Total Revenue Growth (Q YOY) | -50.85% | |||
Earnings Growth (Q YOY) | -108.98% | |||
EPS Diluted (TTM) | -$2.45 | |||
EPS Diluted Growth (Q YOY) | -108.98% | |||
Balance Sheet | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | $5.27M | |||
Cash Per Share (Q) | $6.84 | |||
Total Current Assets (Q) | $6.40M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | $27.56M | |||
Current Ratio (Q) | 2.842 | |||
Book Value Per Share (Q) | $35.72 | |||
Total Assets (Q) | $51.30M | |||
Total Current Liabilities (Q) | $2.25M | |||
Total Debt (Q) | $775.00K | |||
Total Liabilities (Q) | $23.74M | |||
Total Common Equity (Q) | $27.56M | |||
Cash Flow | ACMTA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | $814.20K | |||
Cash from Financing (TTM) | -$75.20K | |||
Net Change in Cash (TTM) | -$1.24M | |||
Levered Free Cash Flow (TTM) | $2.13M | |||
Cash from Operations (TTM) | -$1.98M | |||